A randomised controlled trial (RCT) to assess the incremental costs and clinical benefits of cognitive analytic therapy (CAT) to standard care within community mental health teams in the treatment of severe personality disorder
ISRCTN | ISRCTN88887622 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN88887622 |
Secondary identifying numbers | REC00168 |
- Submission date
- 23/01/2004
- Registration date
- 23/01/2004
- Last edited
- 28/11/2019
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Prof Philip Richardson
Scientific
Scientific
The Tavistock Clinic
120 Belsize Lane
London
NW3 5BA
United Kingdom
Study information
Study design | Randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Not specified |
Study type | Not Specified |
Scientific title | A randomised controlled trial (RCT) to assess the incremental costs and clinical benefits of cognitive analytic therapy (CAT) to standard care within community mental health teams in the treatment of severe personality disorder |
Study objectives | Cognitive-analytic therapy (CAT) has established a claim to make a valuable and economic contribution to the treatment of patients with severe personality disorders. This has been demonstrated in a range of descriptive and clinical case studies though no randomised controlled study has so far established its effectiveness with this severely disturbed patient group. |
Ethics approval(s) | Not provided at time of registration |
Health condition(s) or problem(s) studied | Mental and behavioural disorders: Other mental disorder |
Intervention | 1. 24 sessions of cognitive-analytical therapy (CAT) 2. Standard care |
Intervention type | Other |
Primary outcome measure | Beck Depression Inventory, Structured Clinical Interview for DSM-IV, MCMI-III, Client Service Receipt Interview. |
Secondary outcome measures | Not provided at time of registration |
Overall study start date | 01/07/1998 |
Completion date | 01/07/1999 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Not Specified |
Sex | Not Specified |
Target number of participants | 48 |
Key inclusion criteria | 48 'hard to treat' mental health service users with complex mental health problems who have been in active contact with the participating trusts for at least one year and whose major presenting problems have not been successfully treated. Inclusion criteria: 1. A diagnosis of Cluster B Personality Disorder (Diagnostic and Statistical Manual of Mental Disorders, fourth edition [DSM IV], Axis II - as per Million Clinical Multiaxial Inventory III [MCMI III]) 2. A Beck Depression Index score above 25 3. One year (or longer) history of unsuccessful treatment (assessed by case note review by the responsible medical officers [RMOs]); or at least two hospital admissions in the past 5 years following parasuicide. 4. Still on active caseload of Community Mental Health Team (CMHT) (Care Programme Approach [CPA] level 1 or higher). |
Key exclusion criteria | 1. Concurrent organic or definite psychotic illness (though patients suffering micropsychotic episodes only will not be excluded) 2. Referral to CAT services in past five years 3. Currently receiving another formal psychological treatment 4. Current admission to inpatient care (though subsequent admission during the course of the trial will not exclude patients from further follow-up) 5. Current active substance abuse (including alcohol) |
Date of first enrolment | 01/07/1998 |
Date of final enrolment | 01/07/1999 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
The Tavistock Clinic
London
NW3 5BA
United Kingdom
NW3 5BA
United Kingdom
Sponsor information
NHS R&D Regional Programme Register - Department of Health (UK)
Government
Government
The Department of Health
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
Phone | +44 (0)20 7307 2622 |
---|---|
dhmail@doh.gsi.org.uk | |
Website | http://www.doh.gov.uk |
Funders
Funder type
Government
NHS Executive London
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Editorial Notes
28/11/2019: No publications found. All search options exhausted.